CBD interferes with the same liver enzymes that break down a wide range of common medications, potentially causing those drugs to build up to higher levels in your blood than intended. The interactions range from mild side effects to serious safety concerns, depending on the medication. Here’s what you need to know about the most significant ones.
Why CBD Causes Drug Interactions
Your liver uses a family of enzymes to break down most medications. CBD inhibits several of these enzymes, particularly CYP3A4, CYP2C19, and CYP2C9. When CBD blocks these enzymes, medications that rely on them for processing linger in your body longer and reach higher concentrations than expected. CYP3A4 alone handles roughly half of all CBD metabolism, and CYP2C19 accounts for about 31%. Both of these enzymes are also responsible for breaking down dozens of widely prescribed drugs.
CBD acts as a time-dependent inhibitor of CYP2C19, CYP3A, and CYP1A2, meaning its blocking effect can intensify with repeated use. It’s also a reversible inhibitor of CYP2C9. The result is that taking CBD alongside certain medications is functionally similar to taking a higher dose of that medication than prescribed.
Blood Thinners
Warfarin is one of the most well-documented problem drugs to combine with CBD. In a clinical case, a patient whose blood-clotting levels (measured by INR) had been stable for six months saw a sharp, nonlinear increase in INR after starting CBD oil. His warfarin dose ultimately had to be reduced by about 30% to keep his blood within a safe clotting range. The interaction happens because CBD competes with warfarin for the same enzymes and simultaneously inhibits them, making warfarin far more potent than intended. The danger is straightforward: too much active warfarin in your system raises the risk of serious bleeding.
If you take warfarin or similar blood thinners and use CBD, frequent monitoring of your clotting levels is essential during any change in CBD dosing.
Anti-Seizure Medications
Ironically, the FDA-approved CBD medication Epidiolex is prescribed for seizures, yet it interacts significantly with other seizure drugs. Clobazam is the most notable. CBD increases blood levels of clobazam’s active breakdown product, N-desmethylclobazam, by more than threefold. That’s a dramatic increase that can amplify sedation, drowsiness, and other side effects. Studies also found that CBD raised levels of topiramate and rufinamide, two other common anti-seizure medications.
The combination of CBD with valproic acid (valproate) raises a separate concern: liver damage. In clinical trials, 21% of patients taking CBD alongside valproate developed liver enzyme elevations greater than three times the upper limit of normal, compared to just 3% of patients not on valproate. This is a significant enough risk that liver function monitoring is standard for anyone on this combination.
Immunosuppressants
Transplant recipients taking tacrolimus should be particularly cautious. In case studies, patients who had been stable on tacrolimus saw up to a 2.4-fold increase in the drug’s blood concentration after starting CBD. A pilot study in healthy volunteers confirmed that CBD significantly increases both peak levels and total exposure to tacrolimus. Lab testing revealed something striking: CBD and its active metabolite (7-hydroxy-CBD) dramatically prolonged the time it takes for tacrolimus to break down, with effects magnified up to 29-fold in certain enzyme pathways.
This interaction likely extends to other immunosuppressants processed by the same enzymes, including cyclosporine and sirolimus. For transplant patients, even small fluctuations in immunosuppressant levels can mean the difference between a stable organ and rejection, making this one of the highest-risk combinations.
Antidepressants
CBD can raise blood levels of several common antidepressants, particularly those processed by CYP2C19. Sertraline (Zoloft) and escitalopram (Lexapro) are the best-studied examples. In one analysis, patients taking these antidepressants alongside cannabinoids experienced a nearly fivefold increase in cough, a 3.3-fold increase in diarrhea, a 3.3-fold increase in fatigue, and a 2.9-fold increase in dizziness compared to those on the antidepressant alone.
Beyond the enzyme competition, there’s a deeper concern. CBD and other cannabinoids directly affect serotonin signaling in the brain. Long-term cannabinoid use alters the balance of serotonin receptor activity, which could theoretically reduce how well antidepressants work over time. This means the interaction isn’t just about drug levels; it may also change the way your brain responds to the medication itself.
The Grapefruit Rule as a Quick Guide
A practical shortcut: if your medication label warns against grapefruit juice, there’s a reasonable chance CBD could cause a similar interaction. Both grapefruit and CBD inhibit CYP3A4, one of the liver’s most important drug-processing enzymes. This comparison isn’t perfect since CBD also inhibits CYP2C19 and CYP2C9, which grapefruit does not. But the grapefruit rule covers a useful swath of medications, including many statins, calcium channel blockers for blood pressure, certain heart rhythm drugs, and some anti-anxiety medications like buspirone.
The overlap isn’t universal, so don’t treat the grapefruit rule as a complete list. It’s a starting point for identifying potential problems, not a substitute for checking your specific medications.
Other Medications to Watch
The FDA’s prescribing information for Epidiolex flags several additional enzyme pathways that CBD can affect. Beyond the major interactions above, dose reductions may be needed for drugs processed by UGT1A9, UGT2B7, CYP1A2, and CYP2C8. Some specific categories worth noting:
- Opioid pain medications: Methadone has been flagged in adverse event reports when combined with CBD.
- HIV medications: Saquinavir and potentially other protease inhibitors processed by CYP3A4/5 could be affected.
- Statins: These cholesterol-lowering drugs are processed by CYP3A4 and CYP3A5, and CBD may increase their blood levels.
- Cancer drugs: Tamoxifen, vincristine, and other chemotherapy agents rely on enzymes CBD inhibits.
Does Dose Matter?
The severity of CBD’s drug interactions appears to be dose-dependent, but there’s no universally agreed-upon safe threshold. Clinical trials showing major interactions typically use prescription-grade CBD at doses of 5 to 20 mg per kilogram of body weight per day, which for an average adult translates to hundreds of milligrams daily. One case report found minimal impact on warfarin clotting levels when a patient used an oromucosal cannabis product at relatively low cannabinoid concentrations, suggesting the blood levels of CBD were too low to meaningfully block enzymes.
Another case examined 40 mg per day of CBD in a patient on tamoxifen and found limited interaction at that low dose. However, the CBD products sold as supplements vary enormously in actual CBD content, and even “low-dose” products taken consistently could accumulate enough to cause problems with sensitive medications. The safest approach is to treat any regular CBD use as a potential interaction risk, especially with the high-risk drug categories listed above.